Larvol Delta - Safety-Tolerability-and-Pharmacokinetic-Study-of-TRK250-for-Patients-With-Idiopathic-Pulmonary-Fibrosis

TRK-250 - Toray, BONAC Corporation

http://clinicaltrials.gov/ct2/show/NCT03727802

Jun 16, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next